Business
Currency:EUR
2024/Q1
Stock NameRevenueRatio
Biopharmaceutical and Diagnostic Solutions199.42M84.50%
Engineering77.34M32.77%
Adjustments, eliminations and unallocated items-40.77M-17.28%
Region
Currency:EUR
2023/FY
Stock NameRevenueRatio
EMEA634.05M58.42%
North America317.54M29.26%
APAC102.9M9.48%
South America30.87M2.84%